Gilead Sciences Completes 315B Acquisition of Tubulis to Strengthen Oncology Pipeline Nvidia and Asias Three Chip Giants Capture Record Gains from AI Boom HFCL Shares Jump 9 to AllTime High After Securing 135 Crore RailTel Order Micron Technology Achieves 1 Trillion Market Cap Milestone Amid AIDriven Memory Demand Couple Feigns Financial Strain to Maintain Social Circle A Behavioral Finance Perspective Nvidia Beats Expectations as AI Boom Drives 85 Revenue Surge Yet Shares Dip on Competitive Concerns OppFi Inc OPFI Q1 2026 Earnings EPS Beat Drives Positive Sentiment Despite Revenue Uncertainty RNG Q1 2026 Earnings EPS Beats Estimates Narrowly as Stock Pulls Back Brookfield Wealth Solutions BNT Q4 2024 Earnings Modest EPS amid Quiet Quarter Modular Medical Inc MODD Q3 2025 Earnings EPS Misses Estimates Amid Operational Challenges Stock Surges 1344 HROW Q1 2026 Earnings EPS Misses Estimates Significantly as Company Navigates Operational Challenges MSI Q1 2026 Earnings EPS Beat Expectations on Solid Operational Execution Apple Hospitality REIT APLE Edges Lower Testing Key Support Around 1450 Axogen Inc AXGN Edges Lower Amid Sector Rotation Key Support Levels in Focus Columbus Acquisition Corp COLA Edges Higher Amid Modest Uptick Founder Group Limited FGL Posts Modest Gain Testing Resistance After Base Building Triple Flag Precious Metals TFPM Slips 36 Approaches Key Support at 292 Taylor Swifts Chart Dominance Stalled Ordinary Blocks The Fate of Ophelia for 12 Weeks on Adult Contemporary Pfizer Clinches Trademark Victory in Singapore Against Merck Over Vaccine Brand Intel Urges PC Makers to Adopt Latest Chips Amid AI Demand Potential Margin Catalyst APEC Talks Highlight Persistent USChina Trade Gaps Three Key Signs Government Plans Overhaul of CBEC to Ensure Seamless GST Implementation Welfare Spending Imbalance Alan Milburn Calls for Youth Employment Reforms Over Benefits Expenditure Michael Price Highlights Contrarian Value Investing Amid Market Volatility LAMR Q1 2026 Earnings EPS Beat Highlights Strong Profitability Myriad Genetics MYGN Slips as Stock Navigates Support Levels Near 359